[ad_1]
Photograph Credit score: kate_sept2004 / Getty Photos
SOURCES:
Kimberley Lee, MD, assistant member, division of breast oncology, Moffitt Most cancers Middle.
Rachel Greenup, MD, affiliate professor of surgical procedure (oncology, breast), Yale Faculty of drugs; chief, breast surgical procedure, The Breast Middle at Smilow Most cancers Hospital.
Anne Marie McCarthy, PhD, assistant professor of epidemiology, Perelman Faculty of Medication, College of Pennsylvania.
Eric Winer, MD, professor of pharmacology; professor of drugs (medical oncology), Yale Faculty of Medication; director, Yale Most cancers Middle; physician-in-chief, Smilow Most cancers Community.
Frontiers in Molecular Biosciences: “Triple-Unfavorable Breast Most cancers: A Temporary Overview About Epidemiology, Danger Elements, Signaling Pathways, Therapy and Position of Synthetic Intelligence.”
American Most cancers Society: “Breast Most cancers Danger Elements You Can’t Change,” “Examine: New Genes Linked With Triple-Unfavorable Breast Most cancers,” “American Most cancers Society Suggestions for the Early Detection of Breast Most cancers.”
Journal of the Nationwide Most cancers Institute: “Triple-Unfavorable Breast Most cancers Danger Genes Recognized by Multigene Hereditary Most cancers Panel Testing.”
CDC: “Household Well being Historical past and the BRCA1 and BRCA2 genes,” “Household Well being Historical past Danger Classes,” “BRCA Gene Mutations.”
Present Breast Most cancers Experiences: “Disparities in Genetic Testing and Care amongst Black girls with Hereditary Breast Most cancers.”
JAMA Surgical procedure: “Analysis of Triple-Unfavorable Breast Most cancers Early Detection by way of Mammography Screening and Outcomes in African American and White American Sufferers.
[ad_2]
